Urine proteomics: the present and future of measuring urinary protein components in disease - Wikidata - awgldk - TriplyDB

Urine proteomics: the present and future of measuring urinary protein components in disease

Urine proteomics: the present and future of measuring urinary protein components in disease

http://www.wikidata.org/entity/Q35929449

about

Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes Urinary Markers of Tubular Injury in Early Diabetic Nephropathy Diagnosis of prostate cancer via nanotechnological approach Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease Haemolytic anaemia after nitrofurantoin treatment in a pregnant woman with G6PD deficiency Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy Urine collection and processing for protein biomarker discovery and quantification.A computational method for prediction of excretory proteins and application to identification of gastric cancer markers in urine.Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin Detection of differential levels of proteins in the urine of patients with endometrial cancer: analysis using two-dimensional gel electrophoresis and o-glycan binding lectin Standardization of diagnostic biomarker concentrations in urine: the hematuria caveat.Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig model Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.Using an isolated rat kidney model to identify kidney origin proteins in urine.Detection of renal tissue and urinary tract proteins in the human urine after space flight.Urine podocyte mRNAs mark disease activity in IgA nephropathy.Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients.Urine Levels of Defensin α1 Reflect Kidney Injury in Leptospirosis Patients.Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for kidney allograft rejection.Urinary biomarkers in obstructive nephropathy Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT)Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy Mast cell interleukin-10 drives localized tolerance in chronic bladder infection Biomarker discovery in mass spectrometry-based urinary proteomics.Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis Immunoaffinity capillary electrophoresis as a powerful strategy for the quantification of low-abundance biomarkers, drugs, and metabolites in biological matrices.Molecular signatures of obstructive sleep apnea in adults: a review and perspective.Proteomic Biomarkers of Atherosclerosis.Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes.Urinary interleukin-6 as a predictor of radiographic progression in rheumatoid arthritis: A 3-year evaluation.An overview of proteomic and metabolomic technologies and their application to pregnancy research.A compendium of urinary biomarkers indicative of glomerular podocytopathy.Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma.

P2860

Q26744419-59B41C5B-C39B-4A8F-ABD4-7895FCDD1736 Q26746921-89B7581B-53AB-42F5-9206-F768D0B06718 Q26777322-A955BB63-61FC-4DCC-836E-360E2D100D9C Q28474977-005D4015-1C75-431B-A44E-215A44131582 Q33597457-DEF7972C-F031-4C24-998E-758A94AF3288 Q33628578-94178B16-59F9-4CDF-B20F-5B25EE302C94 Q33645242-94145FF0-09F5-4C6C-B31F-A05A67C0AF0E Q33780855-4E281C8E-DFCB-4749-9001-FDFECAAF94B9 Q33834185-E0A2BBC2-2D82-4348-9875-9E2478093392 Q34187912-8043EFF4-A21B-423F-BF54-5551928417F7 Q34369626-5D6A0FBC-7FFC-4C41-8DA2-60C2DB0D3AE3 Q34387861-276A9DE9-3919-422A-9138-15389AA33045 Q34403486-158404D7-F246-478C-99F9-FF9BEDC59DE2 Q34541867-C5ED4D82-6650-4FCC-A20A-45C357342EAA Q34552696-5D97E83A-7158-4E65-8DDA-2A03BFBE1C24 Q34631821-3D85E560-C29D-4525-ADFB-1F095B5D8A3F Q34664488-299F74E2-CF0B-4C8D-B946-8BB998F5E91C Q34794421-0C0A38EA-01FF-4FAE-898B-1521BD81F205 Q34964281-B40F0D96-B701-41A4-AE1C-CFF0808E6E82 Q35777614-59B1575E-AF23-477C-888D-B1FE8B34B985 Q35878999-91A92FCA-C959-4FC6-B6CB-1C677E86F9E4 Q36011264-9FC2813F-C813-45D0-B898-95DC8076E929 Q36046534-B40252A0-87FC-4A44-A100-B6C915918266 Q36149839-25F6A3E2-2CBF-434B-9954-52F441600955 Q36241222-73E421DE-4233-453A-8FE1-0D7A6479A58D Q36294380-A84F2D85-E2E8-4964-AD0A-C71020AEF844 Q36453078-C01F9017-560D-44D7-BC05-184C72AAAED0 Q36556271-D522225A-1F50-4EFF-AFB3-772AE037794C Q36629471-7B6B632F-0927-450A-A3AD-3A4396534813 Q36826092-7A38F359-4E22-49FE-9A50-614BA7FA9167 Q36956324-233A78CE-D4C4-4CE6-93C4-A943942D4C47 Q36968011-22D903AA-921C-43C1-99B9-CCA9417A93BE Q37137414-5FDD3B9A-47EF-4636-B23F-33775862A01C Q37146506-1F4AFB67-7E3D-4D6E-B497-8CD0C5277338 Q37207340-7E023A9B-9024-4585-939D-46EAD52C232E Q37313140-6A2740B6-2EBE-4CD8-BA5F-282B8161E75F Q37330396-CEBD1032-70DD-4828-9150-404249B81D08 Q37348801-47C9F985-7144-450C-AC9C-916DF9A8993F Q37353481-13284BF4-13D0-45D4-9A29-46844C0F5C88 Q37400502-FBEE5B85-2ECB-4951-B3B6-74D3106CA740

P2860

Urine proteomics: the present and future of measuring urinary protein components in disease

http://www.wikidata.org/entity/Q35929449

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Urine proteomics: the present ...... protein components in disease

@ast

Urine proteomics: the present ...... protein components in disease

@en

type

label

Urine proteomics: the present ...... protein components in disease

@ast

Urine proteomics: the present ...... protein components in disease

@en

prefLabel

Urine proteomics: the present ...... protein components in disease

@ast

Urine proteomics: the present ...... protein components in disease

@en

P1433

Q35929449-9043A620-2D05-4862-A8BE-792F715CFCD4

P1476

Q35929449-5F6B5C87-013F-4E7C-AF48-21C9F7743122

P2093

Q35929449-17E015A0-FCC3-4671-922E-03DFBEBDCAB5

Q35929449-B8DA076C-EA35-495A-9C46-873951854470

P2860

Q35929449-1476FAA1-DA56-4FB1-B688-1379C285A242

Q35929449-1CD8BFC6-2D6E-42C0-8A79-A65E28AD1307

Q35929449-2DA6C883-6164-4E89-ADD6-76EF2B7981C1

Q35929449-3557C6A8-380D-4E8C-A6C6-AC07CEA488DD

Q35929449-3A092712-05A7-4449-B735-A3C8CCEAB739

Q35929449-3B745628-F72B-47C9-ACC2-4A5C0702F633

Q35929449-3E043367-0E4B-4BF4-BC35-744E36D6E0AA

Q35929449-3FB6E027-644B-4E7D-B0A4-6295253F6172

Q35929449-40AA2A6D-113A-4737-9A73-E6604B64E16B

Q35929449-4471A49E-2D47-46A5-A98A-BE43C82A1267

P304

Q35929449-73956EA7-12E4-4B49-A9C5-4A0F756CFD56

P31

Q35929449-A187CDC9-67C2-4F97-9BB9-36F8AAD01974

P356

Q35929449-0DA65309-6D04-4EBC-B563-9391FF0C97AF

P407

Q35929449-41E5ABD8-E999-4E13-9945-A3EBF6E6432D

P433

Q35929449-1F48B81F-E577-458E-934A-08BDED34AF2D

P478

Q35929449-614AD0B4-4D2E-4A2B-A76E-720AB10A66E6

P577

Q35929449-B1F99712-E19B-48A4-B041-D79698EB0DCB

P5875

Q35929449-3E85A807-8B19-4B76-83E6-27FBEDF292D6

P698

Q35929449-CE265452-FEC5-4749-A2BF-33AFF06E8098

P932

Q35929449-1416F7D7-37FC-41D1-8C08-D533AFAFDA6B

P356

P1433

Canadian Medical Association Journal

P1476

Urine proteomics: the present ...... protein components in disease

@en

P2093

Jonathan Barratt

http://www.w3.org/2001/XMLSchema#string

Peter Topham

http://www.w3.org/2001/XMLSchema#string

P2860

Pathway analysis of kidney cancer using proteomics and metabolic profiling

Current two-dimensional electrophoresis technology for proteomics

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Characterization of renal allograft rejection by urinary proteomic analysis.

Bioinformatic analysis of the urine proteome of acute allograft rejection.

Different techniques for urinary protein analysis of normal and lung cancer patients.

Establishment of a 2-D human urinary proteomic map in IgA nephropathy.

Detection of bile salt-dependent lipase, a 110 kDa pancreatic protein, in urines of healthy subjects.

Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome.

Urinary proteomic profiles distinguish between active and inactive lupus nephritis.

P304

361-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.061590

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6140477

http://www.w3.org/2001/XMLSchema#string

P698

17698825

http://www.w3.org/2001/XMLSchema#string

P932

1942114

http://www.w3.org/2001/XMLSchema#string